glp 1 rezeptor antagonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Glucagon-like peptide-1 receptor: mechanisms and
Description
All participants were T2DM patients being treated with a combination of metformin, sodium-glucose co-transporter-2, or sulfonylurea
A medication review should be conducted to identify drugs that might contribute to cramping (statins, diuretics)
No pharmaceutical sponsorship whatsoever
We calculated averages of participated trials every 20 trials, thus studying three blocks
